Fresh Tracks Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2012 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Fresh Tracks Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q4 2023.
  • Fresh Tracks Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2023 was -58.8 %, a 65.1% increase year-over-year.
  • Fresh Tracks Therapeutics, Inc. annual Return On Equity for 2023 was -58.8 %, a 65.1% increase from 2022.
  • Fresh Tracks Therapeutics, Inc. annual Return On Equity for 2022 was -168 %, a 2.83% decline from 2021.
  • Fresh Tracks Therapeutics, Inc. annual Return On Equity for 2021 was -164 %, a 40.3% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -58.8 +110 +65.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -99.8 +33.7 +25.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -189 -32.5 -20.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -145 +46.1 +24.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -168 -4.63 -2.83% Oct 1, 2022 Dec 31, 2022
Q3 2022 -134 +31.9 +19.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -156 -25.2 -19.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -192 -82.7 -76% Jan 1, 2022 Mar 31, 2022
Q4 2021 -164 -47.1 -40.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -165 +22 +11.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -131 +61.9 +32.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -109 -361 -143% Jan 1, 2021 Mar 31, 2021
Q4 2020 -117 -205 -232% Oct 1, 2020 Dec 31, 2020
Q3 2020 -187 -223 -627% Jul 1, 2020 Sep 30, 2020
Q2 2020 -193 -214 -1011% Apr 1, 2020 Jun 30, 2020
Q1 2020 252 +231 +1079% Jan 1, 2020 Mar 31, 2020
Q4 2019 88.2 +74.1 +527% Oct 1, 2019 Dec 31, 2019
Q3 2019 35.6 +20.8 +140% Jul 1, 2019 Sep 30, 2019
Q2 2019 21.2 -5.82 -21.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 21.4 -69.9 -76.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 14.1 +100 Oct 1, 2018 Dec 31, 2018
Q3 2018 14.8 +43.9 Jul 1, 2018 Sep 30, 2018
Q2 2018 27 +53.1 Apr 1, 2018 Jun 30, 2018
Q1 2018 91.3 +112 Jan 1, 2018 Mar 31, 2018
Q4 2017 -86.1 -66.1 -329% Oct 1, 2017 Dec 31, 2017
Q3 2017 -29.1 -9.94 -52% Jul 1, 2017 Sep 30, 2017
Q2 2017 -26.1 -11.9 -84% Apr 1, 2017 Jun 30, 2017
Q1 2017 -21.1 -3.97 -23.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -20.1 -0.58 -2.98% Oct 1, 2016 Dec 31, 2016
Q3 2016 -19.1 +4.38 +18.6% Jul 1, 2016 Sep 30, 2016
Q2 2016 -14.2 +16.3 +53.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -17.1 +14.4 +45.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -19.5 +10.1 +34.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 -23.5 +0.68 +2.81% Jul 1, 2015 Sep 30, 2015
Q2 2015 -30.5 +2.15 +6.59% Apr 1, 2015 Jun 30, 2015
Q1 2015 -31.5 +8.35 +20.9% Jan 1, 2015 Mar 31, 2015
Q4 2014 -29.6 +15.5 +34.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -24.2 +23.8 +49.7% Jul 1, 2014 Sep 30, 2014
Q2 2014 -32.7 +8.11 +19.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -39.9 -4.75 -13.5% Jan 1, 2014 Mar 31, 2014
Q4 2013 -45.1 -22 -95.7% Oct 1, 2013 Dec 31, 2013
Q3 2013 -48 -24.2 -102% Jul 1, 2013 Sep 30, 2013
Q2 2013 -40.8 -43.3 -1677% Apr 1, 2013 Jun 30, 2013
Q1 2013 -35.1 -37.5 -1616% Jan 1, 2013 Mar 31, 2013
Q4 2012 -23 Oct 1, 2012 Dec 31, 2012
Q3 2012 -23.8 Jul 1, 2012 Sep 30, 2012
Q2 2012 2.58 Apr 1, 2012 Jun 30, 2012
Q1 2012 2.32 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.